<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"16p11 2":1,
"9q22":1,
"Extraskeletal myxoid chondrosarcoma":1,
"FUS":1,
"NR4A3":1,
"complication":1,
"hematoma":1,
"neck dissection":1,
"risk factor":1,
"thyroid surgery":1,
"anaplastic thyroid carcinoma":2,
"oncolytic virus":1,
"surgery":3,
"vaccinia":1,
"viral therapy":1,
"diagnostic accuracy":1,
"thyroid nodules":2,
"thyroid reporting and data system":1,
"18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)":1,
"differentiated thyroid carcinoma":5,
"meta-analysis":2,
"negative radioiodine whole-body scan":1,
"thyroid cancer":12,
"chondrosarcoma":1,
"cricoid reconstruction":1,
"laryngotracheal reconstruction":1,
"laryngotracheal stenosis":1,
"subglottic stenosis":1,
"temporoparietal fascial flap":1,
"tracheal reconstruction":1,
"vascularized composite autograft (VCAG)":1,
"cervical":1,
"frozen sections":1,
"lymph node":2,
"metastasis":8,
"papillary thyroid carcinoma":9,
"Anterior commissure":1,
"Invasion":2,
"Laryngeal cancer":1,
"Thyroid cartilage":2,
"breast carcinoma":1,
"immunohistochemistry":6,
"invasive micropapillary carcinoma":1,
"arterial stiffness":1,
"central blood pressure":1,
"global longitudinal strain":1,
"hypertension":1,
"pulse wave velocity":1,
"vascular endothelial growth factor receptor":1,
"Castleman disease":1,
"Positron emission tomography":2,
"Ultrasonography":2,
"Carbon nanoparticles":1,
"Parathyroid":1,
"Reoperation":1,
"131I-SPECT/CT":1,
"Stimulated serum thyroglobulin":1,
"breast cancer":2,
"lung cancer":4,
"triple negative breast cancer":1,
"Genetics":1,
"Mouse modeling":1,
"Pre-clinical models":1,
"Hürthle cell tumors":1,
"Immune-histochemical markers":1,
"Thyroid malignancy markers":1,
"Akt":1,
"HDAC inhibitor":1,
"SNX5422":1,
"Synergism":1,
"Diabetes insipidus":1,
"Metastases":1,
"Pituitary":2,
"ANTIBODIES":1,
"DIAGNOSIS":2,
"METHODOLOGY":1,
"airway":1,
"anastomosis":1,
"cricoid":1,
"resection":1,
"trachea":1,
"BRAF fusions":1,
"NGS":1,
"Sptizoid melanoma":1,
"cancer":5,
"comprehensive genomic profiling":1,
"pancreatic acinar carcinoma":1,
"pilocytic astrocytoma":1,
"solid tumors":1,
"targeted therapy":2,
"Biliary tract":1,
"TTF-1":2,
"choledocho":1,
"Ferulic acid":1,
"TT cells":1,
"URG4/URGCP":1,
"Thyroid":10,
"fine needle aspiration cytology":1,
"gene expression testing":1,
"Bayesian model averaging":1,
"cancer risk estimation":1,
"dose-response model":1,
"radiation epidemiology":1,
"Angiogenesis":1,
"CXCR7":1,
"Chemokine receptor":1,
"Interleukin-8":1,
"Thyroid neoplasms":3,
"Vascular endothelial growth factor":1,
"Collagen IV":1,
"Epidermal growth factor receptor":1,
"Prognosis":4,
"Quantum dot":1,
"Triple-negative breast cancer":1,
"neurocognitive dysfunction":1,
"pediatric cancer":1,
"proton therapy":1,
"radiation therapy":1,
"radiobiological risk estimates":1,
"ESCC":1,
"Kazakh":1,
"Malignant phenotype":1,
"PKM2":3,
"DTC":2,
"FDG":1,
"PET/CT":1,
"PET/MRI":1,
"Afirma":1,
"atypia of undetermined significance":1,
"fine-needle aspiration":3,
"follicular lesion of undetermined significance":1,
"follicular neoplasia":1,
"gene expression classifier":2,
"indeterminate cytology":1,
"Central neck dissection":1,
"Lymph node metastasis":1,
"Papillary carcinoma":2,
"diagnoses and examinations":1,
"gastric cancer":2,
"polymerase chain reaction":1,
"sentinel lymph node":1,
"Basement membrane":1,
"CAM":1,
"CEA":1,
"CSF":1,
"Carcinoembryonic antigen":1,
"Cell adhesion molecule":1,
"Cerebellum":1,
"Cerebrospinal fluid":1,
"DWI":1,
"Diffusion-weighted imaging":1,
"Enterogenous cyst":1,
"FLAIR":1,
"Fluid-attenuated inversion recovery":1,
"GFAP":1,
"Glial fibrillary acidic protein":1,
"MRI":1,
"Magnetic resonance imaging":1,
"N-CAM":1,
"Neural cell adhesion molecule":1,
"PAS":1,
"Periodic acid-Schiff":1,
"Thyroid transcription factor-1":1,
"Bone geometry":1,
"Bone mineral density":1,
"TSH suppression":1,
"CT":1,
"Fiberoptic endoscopy":1,
"Goiter":1,
"Substernal":1,
"Analyses, DNA sequence":1,
"Anaplasia":1,
"BRAF mutation, human":1,
"Squamous cell carcinoma":2,
"endocrine disease":1,
"lymph node metastases":1,
"medullary thyroid carcinoma":2,
"pediatric oncology":1,
"Hypopharynx":1,
"Larynx":2,
"Thyroid gland":2,
"CXCL16":1,
"macrophages":1,
"131I":1,
"53BP1":1,
"DNA damage":1,
"DSB focus assay":1,
"absorbed dose to blood":1,
"biological dosimetry":1,
"differentiated thyroid cancer":3,
"dose response":1,
"radioiodine therapy":2,
"γ-H2AX":1,
"acral melanoma":1,
"metachronous cancer":1,
"nonacral melanoma":1,
"other primary systemic cancer":1,
"prechronous or synchronous":1,
"Adenoma":1,
"Dwarfism":1,
"Hypothyroidism":1,
"Rat":1,
"microcarcinoma":1,
"risk":2,
"thyroid-stimulating hormone":1,
"carcinoid":1,
"goblet cell":1,
"mucinous":1,
"ovary":1,
"struma ovarii":1,
"teratoma":1,
"Elastography":2,
"Non-diagnostic cytology":1,
"Thyroid nodule":3,
"OSNA":1,
"Pediatric carcinoma":1,
"Pediatric head and neck malignancies":1,
"Pediatric head and neck tumors":1,
"Pediatric malignancies":1,
"Pediatric sarcomas":1,
"Pediatric tumors":1,
"Environmental exposure":1,
"Neoplasm":1,
"Radiation":1,
"BRAF":2,
"Bone density":1,
"Thyrotropin":1,
"Apoptosis":2,
"apoptosis signal-regulating kinase 1":1,
"orphan receptor 1":1,
"thyroid transcription factor 1":1,
"follicular carcinoma":1,
"Bethesda system":1,
"cytotechnologist performance":1,
"cytotechnologist-cytopathologist":1,
"fine needle aspiration":1,
"interobserver agreement":1,
"galectin-3":1,
"papillary thyroid microcarcinoma":2,
"Bevacizumab":1,
"Colorectal cancer":1,
"Conversion":1,
"Liver metastasis":1,
"Liver resection":1,
"Neoadjuvant chemotherapy":1,
"mFOLFOX6":1,
"Benign and malignant focal liver lesions":1,
"Hardness":1,
"Bexarotene":1,
"Bexaroteno":1,
"Cholesterol":1,
"Colesterol":1,
"Cutaneous T-cell lymphoma":1,
"Función tiroidea":1,
"Linfoma cutáneo de células T":1,
"Thyroid function":1,
"Discriminant analysis":1,
"Electrocardiogram":1,
"Short-term overt hypothyroidism":1,
"estrogen":1,
"tumor microenvironment":1,
"Adverse endocrine events":1,
"Brachytherapy":1,
"Head and neck":1,
"Paediatric oncology":1,
"Pituitary dysfunction":1,
"Radiotherapy":1,
"Rhabdomyosarcoma":1,
"Cell cycle":1,
"Differentially expressed genes":1,
"ECM degradation":1,
"Enrichment analysis":1,
"RNA-sequencing":1,
"ST6GALNAC family":1,
"human follicular thyroid carcinoma cell line":1,
"invasive properties":1,
"miR-4299":1,
"tumorigenicity":1,
"CCDC67":1,
"molecular pathogenesis":1,
"prognostic marker":1,
"tumor suppressor":2,
"World Trade Center":1,
"cohort study":1,
"epidemiology":1,
"surveillance":1,
"BRAFV600E":1,
"cell signaling":1,
"drug resistance":1,
"vemurafenib":1,
"microRNA-let-7a":1,
"Circulating epithelial cells":1,
"Epithelial cell adhesion molecule":1,
"Thyroglobulin":2,
"Ovarian cancer":1,
"Prostate cancer":1,
"Ultrasound image":1,
"Wavelet transform":1,
"IR820":1,
"amino-glucose":1,
"heat shock protein 70":1,
"near infrared hyperthermia":1,
"tumor targeting":2,
"ABCG2":1,
"Anaplastic thyroid cancer":2,
"CD133":2,
"Cancer stem cells":1,
"Nestin":1,
"Protein Pathway Array":1,
"Signaling pathway":1,
"Anterior commissure of the larynx":1,
"Squamous-cell carcinoma":1,
"Supracricoid laryngectomy":1,
"Head and neck squamous cell carcinoma":1,
"clinical trials":1,
"drug therapy":1,
"hepatocellular carcinoma":1,
"lenvatinib":2,
"sorafenib":1,
"SIRT6":1,
"deacetylation":1,
"Metastatic":1,
"Mutation":1,
"Primary":1,
"Thyroid carcinoma":1,
"incidental":1,
"incidentaloma":1,
"nuclear medicine":1,
"BRAF V600E":1,
"activatable cell penetrating peptide":1,
"laryngoscopy":1,
"murine model":1,
"papillary thyroid cancer":2,
"surgical molecular guidance":1,
"CD44":1,
"Medullary thyroid carcinoma (MTC)":1,
"cancer stem cells (CSCs)":1,
"lymphatic metastasis":1,
"time":1,
"ERBB2":1,
"MicroRNA-375":1,
"Cancer stem/progenitor cells":1,
"ER-α36":1,
"Epigallocatechin-3-gallate":1,
"Epithelial growth factor receptor":1,
"Curcumin":1,
"Human papillary thyroid carcinoma":1,
"Matrix metalloproteinases":1,
"TGF-β/Smad2/3":1,
"Accident nucléaire":1,
"Iode":1,
"Iodine":1,
"Nuclear power plant accident":1,
"Thyroïde":1,
"Leberfibrose":1,
"Mamma":1,
"Prostata":1,
"Schilddrüsenknoten":1,
"Ultraschall-Elastografie":1,
"acoustic radiation force impulse":1,
"breast imaging reporting and data system":1,
"cirrhose hépatique":1,
"elastographie échographique":1,
"fibrose":1,
"liver fibrosis":1,
"lélastographie statique":1,
"nodules de la thyroïde":1,
"prostate":1,
"shear wave elastography":1,
"strain elastography":1,
"transient elastography":1,
"ultrasound elastography":1,
"élastographie par onde de cisaillement":1,
"élastographie transitoire":1,
"BRAFV600E mutation":1,
"Na+/I- symporter":1,
"Glu2–6-modified minigastrin":1,
"cholecystokinin subtype 2-receptor":1,
"kidney retention":1,
"minigastrin radioligand":1,
"neutral endopeptidase":1,
"phosphoramidon":1,
"749":1,
"gene expression":1,
"prognostic indicators":1,
"Clear-cell renal cell carcinoma":1,
"Functional variants":1,
"Liver cancer":1,
"Melanoma":1,
"Mutation pattern":1,
"Random forest":1,
"Autoimmunity":1,
"Autoimmunité":1,
"Hyperprolactinemia":1,
"Hyperprolactinémie":1,
"Maladies thyroïdiennes":1,
"Prolactin":1,
"Prolactine":1,
"Prolactinoma":1,
"Prolactinome":1,
"Thyroid diseases":1,
"myoferlin protein":1,
"non-small cell lung cancer":1,
"tissue array analysis":1,
"vascular endothelial growth factor receptor-2":1,
"carcinoma showing thymus-like differentiation of the thyroid":1,
"cluster of differentiation 117":1,
"cluster of differentiation 5":1,
"thymus-like":1,
"clinical characteristics":1,
"pathology":1,
"renal cell carcinoma":1,
"thyroid-like follicular carcinoma":1,
"Acromegaly":1,
"Hyperparathyroidism":1,
"Multiple endocrine neoplasia":1,
"Mutation and tumor":1,
"tyrosine kinse inhibitor":1,
"Fine-needle aspiration cytology":1,
"thyroid imaging reporting and data system":1,
"thyroid ultrasound":1,
"Renal cell carcinoma (RCC)":1,
"molecular genetics":1,
"renal tumor":1,
"Catalase":1,
"Glutathione":1,
"Malondialdehyde":1,
"Total antioxidant capacity":1,
"CK19":1,
"CK7":1,
"TTF1":1,
"p63":1,
"Carcinoma":1,
"Infiltration":1,
"Thyroidectomy":1,
"Hurthle":1,
"Oncocytic":1,
"Oxyphilic":1,
"fine-needle aspiration biopsy":1,
"oncocytic changes":1,
"surgical treatment":1,
"Abducens palsy":1,
"clivus":1,
"ocular neuromyotonia":1,
"skull":1,
"FGF 23":1,
"Hypophosphatemia":1,
"Osteomalacia":1,
"Tumor induced osteomalacia":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年2月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
